4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021855
Chief R&D Officer bought 7,692 shares at $0.52 ($4,000)
From the SEC's structured data for this filing
Trades in this filing
Cavanagh William · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 1 in the form | +7,692 | $0.52 | $4,000 | 27,692 | D |
| Open-market purchases · 7,692 sh · avg $0.52 · $4,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 2 in the form Warrant (right to buy) | +3,846 | 705,506 | D |
Loading xslF345X03/rdgdoc.xml…